Position in INCY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,263,459
-$20,191,375 QoQ
Shares Held
130,296
-60.3% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bridgewater Associates, LP holds $275,081,004 across 28 Biotechnology names. INCY ranks #7 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
295,579 | $48,333,078 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
106,592 | $35,268,095 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
511,429 | $33,053,656 | |
| 4 | EXEL |
Exelixis, Inc.
|
480,996 | $20,629,918 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
259,459 | $19,267,425 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,724 | $17,557,471 | |
| 7 | INCY |
Incyte Corp
This page
|
130,296 | $12,263,459 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
46,367 | $11,977,523 |
All Filings in INCY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,263,459 | 130,296 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $32,454,834 | 328,590 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,134,196 | 131,284 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $26,837,120 | 394,084 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $38,009,112 | 627,731 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $46,399,637 | 671,777 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $20,400,575 | 308,632 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,706,499 | 127,128 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $20,885,885 | 366,612 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $23,108,854 | 368,034 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $21,386,396 | 370,199 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $19,779,626 | 317,745 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $19,983,449 | 276,511 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $21,802,141 | 271,441 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $22,940,886 | 344,251 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $29,699,939 | 390,943 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,035,330 | 50,810 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,621,699 | 22,094 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $415,912 | 6,047 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,376,504 | 28,248 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||